Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures

被引:76
作者
Pichon-Riviere, Andres [1 ,2 ]
Drummond, Michael [4 ]
Palacios, Alfredo [1 ,3 ]
Garcia-Marti, Sebastian [1 ]
Augustovski, Federico [1 ,2 ]
机构
[1] Inst Clin Effectiveness & Hlth Policy IECS, Natl Sci & Tech Res Council, C1414CPV, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Publ Hlth, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Dept Econ, Buenos Aires, DF, Argentina
[4] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
来源
LANCET GLOBAL HEALTH | 2023年 / 11卷 / 06期
关键词
TASK-FORCE; CARE; FRAMEWORKS;
D O I
10.1016/S2214-109X(23)00162-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Assessment of the efficiency of interventions is paramount to achieving equitable health-care systems. One key barrier to the widespread use of economic evaluations in resource allocation decisions is the absence of a widely accepted method to define cost-effectiveness thresholds to judge whether an intervention is cost-effective in a particular jurisdiction. We aimed to develop a method to estimate cost-effectiveness thresholds on the basis of health expenditures per capita and life expectancy at birth and empirically derive these thresholds for 174 countries. Methods We developed a conceptual framework to assess how the adoption and coverage of new interventions with a given incremental cost-effectiveness ratio will affect the rate of increase of health expenditures per capita and life expectancy at the population level. The cost-effectiveness threshold can be derived so that the effect of new interventions on the evolution of life expectancy and health expenditure per capita is set within predefined goals. To provide guidance on cost-effectiveness thresholds and secular trends for 174 countries, we projected country-level health expenditure per capita and life expectancy increases by income level based on World Bank data for the period 2010-19. Findings Cost-effectiveness thresholds per quality-adjusted life-year (QALY) ranged between US$87 (Democratic Republic of the Congo) and $95 958 (USA) and were less than 0 & BULL;5 gross domestic product (GDP) per capita in 96% of low-income countries, 76% of lower-middle-income countries, 31% of upper-middle-income countries, and 26% of high-income countries. Cost-effectiveness thresholds per QALY were less than 1 GDP per capita in 168 (97%) of the 174 countries. Cost-effectiveness thresholds per life-year ranged between $78 and $80 529 and between 0 & BULL;12 and 1 & BULL;24 GDP per capita, and were less than 1 GDP per capita in 171 (98%) countries. Interpretation This approach, based on widely available data, can provide a useful reference for countries using economic evaluations to inform resource-allocation decisions and can enrich international efforts to estimate cost-effectiveness thresholds. Our results show lower thresholds than those currently in use in many countries.
引用
收藏
页码:E833 / E842
页数:10
相关论文
共 27 条
  • [1] ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
    Anderson, Jeffrey L.
    Heidenreich, Paul A.
    Barnett, Paul G.
    Creager, Mark A.
    Fonarow, Gregg C.
    Gibbons, Raymond J.
    Halperin, Jonathan L.
    Hlatky, Mark A.
    Jacobs, Alice K.
    Mark, Daniel B.
    Masoudi, Frederick A.
    Peterson, Eric D.
    Shaw, Leslee J.
    [J]. CIRCULATION, 2014, 129 (22) : 2329 - +
  • [2] [Anonymous], 2001, Macroeconomics and health: investing in health for economic development
  • [3] [Anonymous], 2015, Using health technology assessment for universal health coverage and reimbursement systems
  • [4] Chi Y-Ling, 2020, Gates Open Res, V4, P176, DOI 10.12688/gatesopenres.13201.1
  • [5] Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
    Claxton, Karl
    Martin, Steve
    Soares, Marta
    Rice, Nigel
    Spackman, Eldon
    Hinde, Sebastian
    Devlin, Nancy
    Smith, Peter C.
    Sculpher, Mark
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (14) : 1 - +
  • [6] Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use
    Culyer, Anthony J.
    [J]. HEALTH ECONOMICS POLICY AND LAW, 2016, 11 (04) : 415 - 432
  • [7] Drummond MF, 2015, Methods for the economic evaluation of health care programmes
  • [8] Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates
    Edney, Laura C.
    Lomas, James
    Karnon, Jonathan
    Vallejo-Torres, Laura
    Stadhouders, Niek
    Siverskog, Jonathan
    Paulden, Mike
    Edoka, Ijeoma P.
    Ochalek, Jessica
    [J]. PHARMACOECONOMICS, 2022, 40 (01) : 31 - 43
  • [9] Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
    Edney, Laura Catherine
    Afzali, Hossein Haji Ali
    Cheng, Terence Chai
    Karnon, Jonathan
    [J]. PHARMACOECONOMICS, 2018, 36 (02) : 239 - 252
  • [10] Estimating a cost-effectiveness threshold for health care decision-making in South Africa
    Edoka, Ijeoma P.
    Stacey, Nicholas K.
    [J]. HEALTH POLICY AND PLANNING, 2020, 35 (05) : 546 - 555